Scoliosis; Adolescence, Scoliosis Idiopathic
Conditions
Brief summary
This study evaluates in a prospectively collected multicenter cohort the existence, characteristics and determinants of EBPCA, the obtained results and their determinant, the rate of over- and under-treatment and their determinants.
Detailed description
Since an evidence-based personalised conservative approach (EBPCA) to Adolescent Idiopathic Scoliosis has never been checked, the investigators studied a prospectively collected multicenter cohort with the aim to verify in the different clinical situations 1) the existence, characteristics and determinants of EBPCA; 2) the obtained results and their determinant; 3) the rate of over- and under-treatment and their determinants. These results are expected to check the actual evidence in everyday clinic, to provide a benchmark for future studies, and to inform guidelines producers and consequently health policy in high income countries, but also and particularly in low-middle income countries where surgery is difficult due to the high costs, and missing competences and structures.
Interventions
OTHERobservation
patients not treated
OTHERPhysiotherapic scoliosis specific exercise
Specific exercise according to the SEAS (Scientific Exercises Approach to Scoliosis) protocol
DEVICEbrace
different kind of braces being elastic, rigid or very rigid. All devices are custom made. The hours of application per day varied from 18 to 24h.
Sponsors
Istituto Scientifico Italiano Colonna Vertebrale
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* diagnosis of Adolescent Idiopathic Scoliosis (AIS), * curves between 11 and 45° at start, * Risser test between 0 and 2. * Since our Institute receive many participants for a second opinion, we considered only participants in charge, defined as those who came at least three times to our facilities
Exclusion criteria
* previous bracing; * absence of x-rays in the 3 months before/after the start and the end of treatment/observation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients achieving specific results | End of growth as defined as radiological evidence of Risser 5 or Risser 4 and two years of no growth in height. | Outcomes were calculated as number of patients achieving specific results at the end of growth, including: 1) remaining below the significant prognostic thresholds of 30° and 50°; 2) improved or progressed beyond the measurement error of 5°; 3) achieving the treatment aims proposed by the current Guidelines : primary (optimal) and secondary (minimal); 4) receiving under- or over-treatment, that have been defined during study planning in relationship to the ideal final result. |
Countries
Italy
Outcome results
None listed